A Canadian company is facing the prospect of losing its licence to produce and sell cannabis products. It would mark the first time Health Canada has revoked a licence since the country first began regulating the medical marijuana industry.

Ascent Industries and its wholly-owned subsidiary, Agrima Botanicals Corp, have been given until 17th December to satisfy the federal health department that they are in compliance with the law.

Agrima’s licence was partially suspended in September after it was found not to have been meeting all its recordkeeping obligations.

Ascent, a publicly traded company, grows, produces and sells a range of cannabis products, including a number of CBD items.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization